Cel-Sci Corporation

News & Events

Press Releases

In The Media

1. CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

   Business Wire JUL 14, 2025 4:05 PM EDT
   CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM)...
   READ ARTICLE

2. CEL-SCI Announces Pricing of $5.7 Million Offering Priced At-the-Market Under NYSE American Rules

   Business Wire JUL 11, 2025 12:16 PM EDT
   CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM)...
   READ ARTICLE

3. CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer

   Business Wire JUL 11, 2025 9:15 AM EDT
   Strong interest from Saudi investment funds in CEL-SCI, Multikine, and potential joint venture to...
   READ ARTICLE

4. FDA's Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI's Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients

   Business Wire JUN 18, 2025 9:00 AM EDT
   FDA priority review and approval based on interim results sets a positive precedent, paving the p...
   READ ARTICLE

5. CEL-SCI Announces Closing of Public Offering

   Business Wire MAY 23, 2025 4:05 PM EDT
   CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CV...
   READ ARTICLE

6. CEL-SCI Announces Pricing of Public Offering

   Business Wire MAY 21, 2025 8:14 PM EDT
   CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CV...
   READ ARTICLE

7. CEL-SCI Announces Proposed Public Offering

   Business Wire MAY 21, 2025 4:05 PM EDT
   CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CV...
   READ ARTICLE

8. CEL-SCI's Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia

   Business Wire MAY 21, 2025 8:00 AM EDT
   Saudi Arabia’s new Breakthrough Medicine Designation, if granted, would make Multikine ava...
   READ ARTICLE

9. CEL-SCI Announces Combination of Common Stock

   Business Wire MAY 19, 2025 2:40 PM EDT
   CEL-SCI Corporation (NYSE American: CVM) announced today that during its annual Shareholder&#...
   READ ARTICLE

10. CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results

    Business Wire MAY 15, 2025 9:00 AM EDT
    Plans to file for approval with Breakthrough Therapy Designation in Saudi Arabia based on complet...
    READ ARTICLE